NEWS & More

THE LATEST NEWS AND EVENTS

BioCentury highlights GNS-Alexion partnership

FierceBiotech features Alexion-GNS Partnership Targeting Rare Diseases

Rare Disease Report Covers Alexion-GNS REFS Licensing Agreement

GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases